Aboriginal Taiwanese hepatitis B carriers have more favorable viral factors than Han Chinese carriers

Journal of Medical Virology

Volumn 83, Issue 8, 2011, Pages 1326-1331

  Nien, Hsiao Ching ^a,b   Sheu, Jin Chuan ^a,b   Kao, Jia Horng ^b   Chou, Huei Chi ^a   Su, Chien Wen ^a   Chen, Chien Hung ^b  

^a Liver Disease Prevention and Treatment Research Foundation   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Carriers; Genotype; Han Chinese; Taiwan; Taiwanese aborigines; Viral factors

Indexed keywords

AMINOTRANSFERASE; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ABORIGINE; ADULT; ALCOHOL CONSUMPTION; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASSAY; BLOOD SAMPLING; CANCER RISK; CHINESE; CLUSTER ANALYSIS; CONTROLLED STUDY; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; PARASITE PREVALENCE; TAIWAN; VIRUS LOAD;

ADULT; CARCINOMA, HEPATOCELLULAR; CARRIER STATE; DISEASE PROGRESSION; DNA, VIRAL; ETHNIC GROUPS; FEMALE; GENOTYPE; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; TAIWAN; TRANSAMINASES; VIRAL LOAD;

HEPATITIS B VIRUS;

EID: 79959253887     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.22135     Document Type: Article

References (22)

1. Beasley RP. 1988. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 61: 1942-1956.
2. Chen DS. 1993. From hepatitis to hepatoma: Lessons from type B viral hepatitis. Science 262: 369-370.
3. Chen CH, Yang PM, Huang GT, Lee HS, Sung JL, Sheu JC. 2007a. Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants. J Formos Med Assoc 106: 148-155.
4. Chen J, Yin J, Tan X, Zhang H, Chen B, Chang W, Schaefer S, Cao G. 2007b. Improved multiplex-PCR to identify hepatitis B virus genotypes A-F and subgenotypes B1, B2, C1 and C2. J Clin Virol 38: 238-243.
5. Chung DC, Ko YC, Chen CJ, Wu CC, Chen ER, Liaw YF, Hwang SJ. 1988. Seroepidemiological studies on hepatitis B and D viruses infection among five ethnic groups in southern Taiwan. J Med Virol 26: 411-418.
6. Council of Indigenous People Taiwan. 2007. Annual Statistic Report of Health and Population in Taiwanese Aborigines in 2006 and 2007. Available at: (accessed in June, 2009).
7. Gunther S, Li BC, Miska S, Kruger DH, Meisel H, Will H. 1995. A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J Virol 69: 5437-5444.
8. Kao JH. 2002. Hepatitis B viral genotypes: Clinical relevance and molecular characteristics. J Gastroenterol Hepatol 17: 643-650.
9. Kao JH. 2003. Hepatitis B virus genotypes and hepatocellular carcinoma in Taiwan. Intervirology 46: 400-407.
10. Kao JH, Chen DS. 2002. Global control of hepatitis B virus infection. Lancet Infect Dis 2: 395-403.
11. Kao JH, Chen PJ, Lai MY, Chen DS. 2002. Clinical and virological aspects of blood donors infected with hepatitis B virus genotypes B and C. J Clin Microbiol 40: 22-25.
12. Kirschberg O, Schuttler C, Repp R, Schaefer S. 2004. A multiplex-PCR to identify hepatitis B virus-Genotypes A-F. J Clin Virol 29: 39-43.
13. Lee WM. 1997. Hepatitis B virus infection. N Engl J Med 337: 1733-1745.
14. Lin HH, Li YH, Yu JH, Wang YW, Lua AC, Huang LC, Huang SC, Lee ML. 2000. Ethnic and geographic variations in the prevalence of hepatitis A, B and C among aboriginal villages in Hualien, Taiwan. Infection 28: 205-208.
15. Liu CJ, Kao JH, Chen PJ, Lai MY, Chen DS. 2002. Molecular epidemiology of hepatitis B viral serotypes and genotypes in Taiwan. J Biomed Sci 9: 166-170.
16. Liu Y, Hussain M, Wong S, Fung SK, Yim HJ, Lok AS. 2007. A genotype-independent real-time PCR assay for quantification of hepatitis B virus DNA. J Clin Microbiol 45: 553-558.
17. Naito H, Hayashi S, Abe K. 2001. Rapid and specific genotyping system for hepatitis B virus corresponding to six major genotypes by PCR using type-specific primers. J Clin Microbiol 39: 362-364.
18. Shen CY, Lee HS, Huang LC, Tsai KS, Chen DS, Cheng AT. 1996. Alcoholism, hepatitis B and C viral infections, and impaired liver function among Taiwanese aboriginal groups. Am J Epidemiol 143: 936-942.
19. Sorrell MF, Belongia EA, Costa J, Gareen IF, Grem JL, Inadomi JM, Kern ER, McHugh JA, Petersen GM, Rein MF, Strader DB, Trotter HT. 2009. National Institutes of Health consensus development conference statement: Management of hepatitis B. Hepatology 49: S4-S12.
20. Wang LY, Hu CT, Ho TY, Lin HH. 2006. Geographic and ethnic variations of long-term efficacy and immunogenicity of hepatitis B vaccination in Hualien, a HBV hyperendemic area. Vaccine 24: 4427-4432.
21. Yang HI, Yeh SH, Chen PJ, Iloeje UH, Jen CL, Su J, Wang LY, Lu SN, You SL, Chen DS, Liaw YF, Chen CJ. 2008. Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. J Natl Cancer Inst 100: 1134-1143.
22. Yang HI, Sherman M, Su J, Chen PJ, Liaw YF, Iloeje UH, Chen CJ. 2010. Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection. J Clin Oncol 28: 2437-2444.